Close a sale effectively
Helping the customer to a buying decision means uncovering motivators and providing justification for investing in your product over the alternatives.
Closing is not a series of manipulative phrases or word tricks aimed at clinching the deal. Helping the customer to a buying decision means uncovering motivators and providing justification for investing in your product over the alternatives. You can learn to be a better closer by educating yourself on your products and competition.
There are six steps in delivering a highly professional closing sequence:
1. Recommend the product you feel is most appropriate for the customer. Back up your recommendation with an explanation, such as a recap of key features and benefits. Be sure to use the words, "I recommend." This will help you sound more like a consultant than a salesperson.
2. Ask your customers if they have any additional questions or need more information.
3. Describe where your product is available.
4. Explain reimbursement and cost considerations for the product.
5. Ask which treatment option is most suited to their patient needs.
6. Complete the paperwork for sample processing and seek the customer's agreement to prescribe your product.
If you have done a good job developing your sales presentation, you should be able to move with confidence into this effective, assumptive close. It will lead to the most natural and comfortable end of a sales call you can have. PR
GSK Acquires Boston Pharmaceuticals’ Novel FGF21 Analog for Steatotic Liver Disease
May 14th 2025Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash consideration, including $1.2 billion upfront and up to $800 million in milestone payments.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Novo Nordisk’s Sogroya Demonstrates Efficacy in Children with Growth Disorders
May 14th 2025Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
